A5050304067- Breast Lesions and Carcinomas
- Cancer and Skin Lesions
- Global Cancer Incidence and Screening
- BRCA gene mutations in cancer
- Colorectal Cancer Screening and Detection
- Breast Cancer Treatment Studies
- COVID-19 and healthcare impacts
- Cardiac, Anesthesia and Surgical Outcomes
- Cancer Genomics and Diagnostics
- Lung Cancer Treatments and Mutations
- Cancer Diagnosis and Treatment
- Medical Imaging Techniques and Applications
- Cervical Cancer and HPV Research
- Spine and Intervertebral Disc Pathology
- Male Breast Health Studies
- Patient-Provider Communication in Healthcare
- Radiomics and Machine Learning in Medical Imaging
- Hematological disorders and diagnostics
- Behavioral Health and Interventions
- Chronic Lymphocytic Leukemia Research
- Fungal Infections and Studies
- Pain Management and Placebo Effect
- Complementary and Alternative Medicine Studies
- Salivary Gland Tumors Diagnosis and Treatment
- Metastasis and carcinoma case studies
Mayo Clinic in Arizona
2011-2025
Mayo Clinic in Florida
2011-2024
Mayo Clinic
2009-2022
WinnMed
2009-2020
General Department of Preventive Medicine
2011-2014
Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory disorder of the breast that often underrecognized. The exact etiology and pathophysiology are unknown, but milk stasis felt to play role. Classically, this condition noninfectious, many cases noted be associated with Corynebacterium species. Most patients affected parous women mean age 35, have breastfed within five years diagnosis. Patients typically present painful mass symptoms inflammation, these features can...
Abstract: Although much emphasis has been placed on the primary presentations of breast cancer, little focus how systemic illnesses may affect breast. In this article, we discuss that can manifest in We summarize clinical features, imaging, histopathology, and treatment recommendations for endocrine, vascular, inflammatory, infectious, hematologic diseases, as well extramammary malignancies present Despite rarity these manifestations disease, knowledge conditions is critical to appropriate...
Objectives: Integrative therapies have been incorporated increasingly into health and wellness in the United States recent decades. Their potential benefits are under evaluation various situations, including pain symptom relief for cancer patients survivors. This pilot study evaluated whether combining two integrative complementary approaches augments a patient's benefit by reducing postoperative stress, pain, anxiety, muscle tension, fatigue compared with one approach alone. Design:...
Idiopathic granulomatous mastitis (IGM) is an uncommon breast disease often mistaken for infection or abscess. We present a case of IGM diagnosed after prolonged ineffective treatment presumed infectious with Once the diagnosis was made biopsy and further evaluation to exclude other causes disease, sinus tract debridement closure by secondary intent resulted in resolution symptoms our patient. Many cases require immunosuppression steroids, methotrexate extensive surgery. To prevent...
Abstract Male breast cancer is rare, and many patients health care providers are not familiar with this entity. Although the underlying causes well understood, certain populations at higher risk, including gene mutation carriers, men Klinefelter syndrome, ethnic groups. typically presents a later stage than female cancer. A palpable mass most common presentation, but nipple discharge or other changes may be seen. Because number of affected individuals small, prospective trials have been...
10608 Background: Cancer is one of the most feared diseases. Multi-cancer early detection (MCED) tests have potential to expand number cancers that are detected at earlier stages, which could result in better clinical outcomes. However, behavioral impacts based on MCED test results affect utility and value these tests. Methods: Two independent data sources evaluated impact intentions perceptions: a survey general population PRO an trial. A web-based, 30-minute US was used ascertain attitudes...
10520 Background: PATHFINDER (NCT04241796) was a prospective, interventional return of results study that enrolled 6,662 participants (pts) from 7 US institutions to assess clinical implementation blood-based multi-cancer early detection (MCED) test. Test for those with cancer signal detected also included origin prediction designed help guide diagnostic evaluations. We analyzed whether the evaluations in were appropriately directed by predictions, assessed residual risk after negative...